Our forum is experiencing technical difficulties with comments being displayed. We apologize for the inconvience.

Homepage Featured News Archives - The GCS Project

Finding Hope in 2021

Featured in Peoria Magazine. Hope. Our sister never—not for one minute—lost hope. March 15, 2021 marked the third anniversary we remembered our sister, Diane Redington, who lost her courageous three-year battle to gynecologic carcinosarcoma (GCS/MMMT).

Posted: May 10, 2021 | View More »

Study of Rebastinib + Paclitaxel Combination

A Phase 1b/2, Open Label Study of Rebastinib + Paclitaxel Combination for Patients with Advanced or Metastatic Solid Tumors NCT03601897 is a 2-part open label, Phase 1b/2, multicenter study of Rebastinib (DCC-2036), a novel tyrosine switch control inhibitor, orally administered in combination with Paclitaxel. Part 1 evaluated two doses of rebastinib at 50 and 100 […]

Posted: November 11, 2020 | View More »

Study for Recurrent Gynecological Carcinosarcoma

Dr. Arend, an assistant professor and senior scientist at the University of Alabama at Birmingham has received funding from 2 drug companies – Bristol Myers Squib and Exelixis to perform an investigator initiated trial for patients with carcinosarcoma: “A phase II single arm study of cabozantinib plus nivolumab and ipilimumab in women with recurrent gynecological […]

Posted: May 26, 2020 | View More »